메뉴 건너뛰기




Volumn 29, Issue 4, 2005, Pages 190-194

First-trimester screening for chromosomal abnormalities

Author keywords

Chromosomal abnormality; First trimester screening; Free human chorionic gonadotropin; Nasal bone; Nuchal translucency; Pregnancy associated plasma protein A

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

EID: 23644453462     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2005.06.001     Document Type: Conference Paper
Times cited : (116)

References (27)
  • 1
    • 0026562612 scopus 로고
    • Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy
    • K.H. Nicolaides, G. Azar, D. Byrne Fetal nuchal translucency ultrasound screening for chromosomal defects in first trimester of pregnancy Br Med J 304 1992 867 889
    • (1992) Br Med J , vol.304 , pp. 867-889
    • Nicolaides, K.H.1    Azar, G.2    Buyrne, D.3
  • 2
    • 0032146382 scopus 로고    scopus 로고
    • UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation
    • Fetal Medicine Foundation First Trimester Screening Group N.
    • R.J. Snijders, P. Noble, N. Sebire Fetal Medicine Foundation First Trimester Screening Group UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
    • (1998) Lancet , vol.352 , pp. 343-346
    • Snijders, R.J.1    Noble, P.2    Sebire3
  • 3
    • 4043063702 scopus 로고    scopus 로고
    • Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities
    • K.H. Nicolaides Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities Am J Obstet Gynecol 191 2004 45 67
    • (2004) Am J Obstet Gynecol , vol.191 , pp. 45-67
    • Nicolaides, K.H.1
  • 4
    • 0030124329 scopus 로고    scopus 로고
    • Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation
    • J. Hyett, G. Moscoso, G. Papapanagiotou Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation Ultrasound Obstet Gynaecol 7 1996 245 250
    • (1996) Ultrasound Obstet Gynaecol , vol.7 , pp. 245-250
    • Hyett, J.1    Moscoso, G.2    Papapanagiotou, G.3
  • 5
    • 0031926213 scopus 로고    scopus 로고
    • Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation
    • A.P. Souka, R.J.M. Snidjers, A. Novakov Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10-14 weeks of gestation Ultrasound Obstet Gynecol 11 1998 391 400
    • (1998) Ultrasound Obstet Gynecol , vol.11 , pp. 391-400
    • Souka, A.P.1    Snidjers, R.J.M.2    Novakov, A.3
  • 8
    • 0027936511 scopus 로고
    • Maternal age-specific risks for trisomies at 9-14 weeks' gestation
    • R.J.M. Snijders, W. Holzgreve, H. Cuckle Maternal age-specific risks for trisomies at 9-14 weeks' gestation Prenat Diagn 14 1994 543 552
    • (1994) Prenat Diagn , vol.14 , pp. 543-552
    • Snijders, R.J.M.1    Holzgreve, W.2    Cuckle, H.3
  • 9
    • 0028849426 scopus 로고
    • Maternal age and gestational age-specific risks for chromosomal defects
    • R.J.M. Snijders, N.J. Sebire, H. Cuckle Maternal age and gestational age-specific risks for chromosomal defects Fetal Diagn Ther 10 1995 356 367
    • (1995) Fetal Diagn Ther , vol.10 , pp. 356-367
    • Snijders, R.J.M.1    Sebire, N.J.2    Cuckle, H.3
  • 11
    • 0043092168 scopus 로고    scopus 로고
    • Delta- NT or NT MoM: Which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester?
    • K. Spencer, R. Bindra, A.B.J. Nix Delta- NT or NT MoM which is the most appropriate method for calculating accurate patient-specific risks for trisomy 21 in the first trimester? Ultrasound Obstet Gynecol 22 2003 142 148
    • (2003) Ultrasound Obstet Gynecol , vol.22 , pp. 142-148
    • Spencer, K.1    Bindra, R.2    Nix, A.B.J.3
  • 12
    • 15944409220 scopus 로고    scopus 로고
    • Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: Results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening
    • K.H. Nicolaides, K. Spencer, K. Avgidou Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening Ultrasound Obstet Gynecol 25 2005 221 226
    • (2005) Ultrasound Obstet Gynecol , vol.25 , pp. 221-226
    • Nicolaides, K.H.1    Spencer, K.2    Avgidou, K.3
  • 13
    • 20444468193 scopus 로고    scopus 로고
    • Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies
    • K. Avgidou, A. Papageorghiou, R. Bindra Prospective first-trimester screening for trisomy 21 in 30,564 pregnancies Am J Obstet Gynecol 192 2005 1761 1767
    • (2005) Am J Obstet Gynecol , vol.192 , pp. 1761-1767
    • Avgidou, K.1    Papageorghiou, A.2    Bindra, R.3
  • 14
    • 0029847927 scopus 로고    scopus 로고
    • Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation
    • N.J. Sebire, R.J.M. Snijders, K. Hughes Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation Br J Obstet Gynaecol 103 1996 999 1003
    • (1996) Br J Obstet Gynaecol , vol.103 , pp. 999-1003
    • Sebire, N.J.1    Snijders, R.J.M.2    Hughes, K.3
  • 15
    • 20644469454 scopus 로고    scopus 로고
    • Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness
    • H. Vandecruys, S. Faiola, M. Auer Screening for trisomy 21 in monochorionic twins by measurement of fetal nuchal translucency thickness Ultrasound Obstet Gynecol 25 2005 551 553
    • (2005) Ultrasound Obstet Gynecol , vol.25 , pp. 551-553
    • Vandecruys, H.1    Faiola, S.2    Auer, M.3
  • 16
    • 0027962426 scopus 로고
    • Maternal serum pregnancy associated placental protein a and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy
    • M.L. Brizot, R.J.M. Snijders, N.A. Bersinger Maternal serum pregnancy associated placental protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy Obstet Gynecol 84 1994 918 922
    • (1994) Obstet Gynecol , vol.84 , pp. 918-922
    • Brizot, M.L.1    Snijders, R.J.M.2    Bersinger, N.A.3
  • 17
    • 0029421091 scopus 로고
    • Screening for fetal trisomy 21 in the first trimester of pregnancy: Maternal serum free beta-hCG and fetal nuchal translucency thickness
    • P.L. Noble, H.D. Abraha, R.J. Snijders Screening for fetal trisomy 21 in the first trimester of pregnancy maternal serum free beta-hCG and fetal nuchal translucency thickness Ultrasound Obstet Gynecol 6 1995 390 395
    • (1995) Ultrasound Obstet Gynecol , vol.6 , pp. 390-395
    • Noble, P.L.1    Abraha, H.D.2    Snijders, R.J.3
  • 18
    • 0032999749 scopus 로고    scopus 로고
    • A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A
    • K. Spencer, V. Souter, N. Tul A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A Ultrasound Obstet Gynecol 13 1999 231 237
    • (1999) Ultrasound Obstet Gynecol , vol.13 , pp. 231-237
    • Spencer, K.1    Souter, V.2    Tul, N.3
  • 19
    • 0036845341 scopus 로고    scopus 로고
    • Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy
    • K. Spencer, J.A. Crossley, D.A. Aitken Temporal changes in maternal serum biochemical markers of trisomy 21 across the first and second trimester of pregnancy Ann Clin Biochem 39 2002 567 576
    • (2002) Ann Clin Biochem , vol.39 , pp. 567-576
    • Spencer, K.1    Crossley, J.A.2    Aitken, D.A.3
  • 20
    • 0035904786 scopus 로고    scopus 로고
    • Absence of nasal bone in fetuses with Trisomy 21 at 11-14 weeks of gestation: An observational study
    • S. Cicero, P. Curcio, A. Papageorghiou Absence of nasal bone in fetuses with Trisomy 21 at 11-14 weeks of gestation an observational study Lancet 358 2001 1665 1667
    • (2001) Lancet , vol.358 , pp. 1665-1667
    • Cicero, S.1    Curcio, P.2    Papageorghiou, A.3
  • 21
    • 0032435220 scopus 로고    scopus 로고
    • Screening for chromosomal abnormalities at 10-14 weeks: The role of ductus venosus blood flow
    • A. Matias, C. Gomes, N. Flack Screening for chromosomal abnormalities at 10-14 weeks the role of ductus venosus blood flow Ultrasound Obstet Gynecol 12 1998 380 384
    • (1998) Ultrasound Obstet Gynecol , vol.12 , pp. 380-384
    • Matias, A.1    Gomes, C.2    Flack, N.3
  • 22
    • 23644445451 scopus 로고    scopus 로고
    • Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11-13+6 weeks scan
    • S. Faiola, E. Tsoi, I.C. Huggon Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11-13+6 weeks scan Ultrasound Obstet Gynecol 26 2005 22 27
    • (2005) Ultrasound Obstet Gynecol , vol.26 , pp. 22-27
    • Faiola, S.1    Tsoi, E.2    Huggon, I.C.3
  • 23
    • 23644445294 scopus 로고    scopus 로고
    • Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21
    • K.H. Nicolaides, F.A. Chervenak, L.B. McCullough Evidence-based obstetric ethics and informed decision-making by pregnant women about invasive diagnosis after first-trimester assessment of risk for trisomy 21 Am J Obstet Gynecol 2005 in press
    • (2005) Am J Obstet Gynecol
    • Nicolaides, K.H.1    Chervenak, F.A.2    McCullough, L.B.3
  • 25
    • 0346751039 scopus 로고    scopus 로고
    • Screening performance of first-trimester nuchal translucency for major cardiac defects: A meta-analysis
    • G. Makrydimas, A. Sotiriadis, J.P. Ioannidis Screening performance of first-trimester nuchal translucency for major cardiac defects a meta-analysis Am J Obstet Gynecol 189 2003 1330 1335
    • (2003) Am J Obstet Gynecol , vol.189 , pp. 1330-1335
    • Makrydimas, G.1    Sotiriadis, A.2    Ioannidis, J.P.3
  • 26
    • 0029079985 scopus 로고
    • Echocardiographic detection of congenital heart disease in the fetus: Present and future
    • L.D. Allan Echocardiographic detection of congenital heart disease in the fetus present and future Br Heart J 74 1995 103 106
    • (1995) Br Heart J , vol.74 , pp. 103-106
    • Allan, L.D.1
  • 27
    • 23644436270 scopus 로고    scopus 로고
    • Relation between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype
    • A. Atzei, K. Gajewska, I.C. Huggon Relation between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype Ultrasound Obstet Gynecol 26 2005 154 157
    • (2005) Ultrasound Obstet Gynecol , vol.26 , pp. 154-157
    • Atzei, A.1    Gajewska, K.2    Huggon, I.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.